Mass board exodus at 23andMe leaves company with tough decisions ahead

The latest stories trending on MedCity News.

Editor's Pick

Top Story Mass Board Exodus at 23andMe Leaves Company With Tough Decisions Ahead Months after 23andMe CEO Anne Wojcicki publicly stated she wants to take the company she co-founded private, all of the company's independent board directors have resigned. The board letter to Wojcicki stated that its members preferred resigning over continuing to have a difference of view over the direction of the company. Sponsored Best Practices in Achieving Revenue Cycle Excellence Presented by Greenway Health Discover the best practices in revenue cycle management to enhance financial health and streamline administrative processes in healthcare.  Learn More.

Featured News

What Are the Challenges in Building a Consumer-Focused Diagnostic Testing Startup? During a panel discussion at the MedCity News INVEST Digital Health Conference, executives shared the top challenges they're facing in the consumer diagnostic testing space. These challenges include funding and encouraging behavior change. What Will It Take to Improve Healthcare Cybersecurity? During a panel discussion at MedCity News' INVEST Digital Health conference, three healthcare leaders shared their expert insight on what needs to change in order to improve the industry's cybersecurity strategy. Medicare Reimbursement for Doctors is in Critical Condition Doctor's offices are the front door of the American healthcare system. We owe it to them to support H.R. 2474 and put an end to annual Congressional stop-gap spending bills. Disrupting the U.S. "Sickcare" System Real change will come from disrupting the status quo. Advances in AI and a focus on prevention offer a way forward, promising not just financial rewards, but a healthier population, less strain on healthcare, and a future where "healthcare" truly means care.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 8 In this episode, we address a judge's ruling against FTC's ban on non-compete clauses in employment contracts and its implications for healthcare workers. Also, Pfizer's launch of a digital platform providing easy access to providers and medications for migraine patients and vaccine seekers. Finally, Johnson & Johnson's attempt to modify its 340B drug discount program, which offers reduced prices on outpatient medications to hospitals serving uninsured patients. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe